SKIN · SkinHealth Systems Inc.
$0.67
+0.03 (+4.46%)
At close · Jul 30
Market Cap
$86.81M
Shares
129.60M
SkinHealth Systems Inc. Earnings Call Transcripts
Every quarterly earnings call for SkinHealth Systems Inc. (SKIN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲30.3%
$88.79M
−$81,000
'22 Q3
22-11-08
▲26%
$98.13M
$6.53M
'22 Q4
23-02-28
▲14.4%
$86.28M
−$20.26M
'23 Q1
23-05-10
▲13.5%
$117.48M
$3.36M
'23 Q2
23-08-09
▲9.7%
$97.41M
−$73.82M
'23 Q3
23-11-13
▼1.3%
$96.82M
−$9.40M
'23 Q4
24-03-12
▼5.7%
$81.40M
−$679,000
'24 Q1
24-05-09
▼22.9%
$90.59M
$202,000
'24 Q2
24-08-08
▼19.1%
$78.80M
−$18.29M
'24 Q3
24-11-12
▼13.8%
$83.50M
−$10.33M
'24 Q4
25-03-12
▼14.5%
$69.58M
−$10.10M
'25 Q1
25-05-08
▼13.7%
$78.19M
$19.71M
'25 Q2
25-08-07
▼10.3%
$70.66M
−$11.03M
'25 Q3
25-12-04
▼1.3%
$82.37M
−$8.10M
'25 Q4
26-03-12
LATEST
▼6.7%
$64.91M
−$6.63M
'26 Q1
26-05-07
Earnings call
FY26 · Q2
2026-08-06
Second Quarter 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
SkinHealth Systems Inc. Q1 FY2026 Earnings Call
Cautious tone
Consumables business
Innovation pipeline
Installed base and churn
Revenue
$64.91M
▼ 6.7% YoY Diluted EPS
$-0.05
Gross margin
68.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
SkinHealth Systems Inc. Q4 FY2025 Earnings Call
Positive tone
Consumables / boosters
Installed base utilization shift
Provider economics and commercial transformation
Revenue
$82.37M*
▼ 1.3% YoY Gross margin
64.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-12-04
SkinHealth Systems Inc. Q3 FY2025 Earnings Call
Positive tone
China distributor transition
Macro and consumer weakness
Churn in provider base
Revenue
$70.66M
▼ 10.3% YoY Diluted EPS
$-0.09
Gross margin
64.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
SkinHealth Systems Inc. Q2 FY2025 Earnings Call
Confident tone
Consumables and Razor-Razor Blade Model
China Distributor Transition
Margin Expansion and Cost Discipline
Revenue
$78.19M
▼ 13.7% YoY Diluted EPS
$0.03
Gross margin
62.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
SkinHealth Systems Inc. Q1 FY2025 Earnings Call
Positive tone
China distributor transition
Consumables growth and recurring revenue
Tariff exposure
Revenue
$69.58M
▼ 14.5% YoY Diluted EPS
$-0.08
Gross margin
69.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
SkinHealth Systems Inc. Q4 FY2024 Earnings Call
Positive tone
China distributor transition
Consumables and boosters
Cost discipline and profitability
Revenue
$83.50M*
▼ 13.8% YoY Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
SkinHealth Systems Inc. Q3 FY2024 Earnings Call
Balanced tone
Consumables growth and gross margin
Product innovation and HydraLoc HA Booster
Macro headwinds and device sales pressure
Revenue
$78.80M
▼ 19.1% YoY Diluted EPS
$-0.15
Gross margin
51.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
SkinHealth Systems Inc. Q2 FY2024 Earnings Call
Cautious tone
Device sales recovery and capital equipment weakness
Syndeo quality issues and replacement program
Cost reduction and financial discipline
Revenue
$90.59M
▼ 22.9% YoY Diluted EPS
$-0.10
▼ 433.3% YoY Gross margin
45.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
SkinHealth Systems Inc. Q1 FY2024 Earnings Call
Positive tone
Hydrafacial brand and provider relationships
Guidance and financial outlook
Syndeo device / capital equipment
Revenue
$81.40M
▼ 5.7% YoY Diluted EPS
$-0.10
Gross margin
59.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
SkinHealth Systems Inc. Q4 FY2023 Earnings Call
Positive tone
Provider and brand relationships
Syndeo platform and quality issues
Consumables growth and penetration
Revenue
$96.82M*
▼ 1.3% YoY Gross margin
47.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
SkinHealth Systems Inc. Q3 FY2023 Earnings Call
Revenue
$97.41M
▲ 9.7% YoY Diluted EPS
$-0.56
Gross margin
-12.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
SkinHealth Systems Inc. Q2 FY2023 Earnings Call
Revenue
$117.48M
▲ 13.5% YoY Diluted EPS
$0.03
Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
SkinHealth Systems Inc. Q1 FY2023 Earnings Call
Revenue
$86.28M
▲ 14.4% YoY Diluted EPS
$-0.15
Gross margin
62.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
SkinHealth Systems Inc. Q4 FY2022 Earnings Call
Revenue
$98.13M*
▲ 26% YoY Gross margin
67.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
SkinHealth Systems Inc. Q3 FY2022 Earnings Call
Revenue
$88.79M
▲ 30.3% YoY Diluted EPS
$-0.03
Gross margin
69.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
SkinHealth Systems Inc. Q2 FY2022 Earnings Call
Revenue
$103.54M
▲ 55.7% YoY Diluted EPS
$-0.06
Gross margin
67.6%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
SkinHealth Systems Inc. Q1 FY2022 Earnings Call
Revenue
$75.42M
▲ 58.6% YoY Diluted EPS
$-0.13
Gross margin
67.5%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
SkinHealth Systems Inc. Q4 FY2021 Earnings Call
Revenue
$77.89M*
Gross margin
68.7%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
SkinHealth Systems Inc. Q3 FY2021 Earnings Call
Revenue
$68.15M
▲ 97.2% YoY Diluted EPS
$-1.63
Gross margin
67.6%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
SkinHealth Systems Inc. Q2 FY2021 Earnings Call
Revenue
$66.51M
▲ 371.2% YoY Diluted EPS
$-1.52
Gross margin
71.0%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
SkinHealth Systems Inc. Q1 FY2021 Earnings Call
Revenue
$47.54M
Diluted EPS
$-0.09
Gross margin
66.8%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts
CIK
1818093
CUSIP
88331L108
13F (30d)
21 filings
20 filers
Visit website
Investor relations